Variant report
Variant | nsv564782 |
---|---|
Chromosome Location | chr14:47709181-47716040 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:47706399..47708616-chr14:47715847..47717651,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529528755 | chr14:47710202-47710203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149794710 | chr14:47710209-47710210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs36055526 | chr14:47710219-47710220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544469089 | chr14:47710285-47710286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374260616 | chr14:47710298-47710299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561175122 | chr14:47710300-47710301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145724930 | chr14:47710338-47710339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529837742 | chr14:47710369-47710370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs193183054 | chr14:47710386-47710387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200070114 | chr14:47710450-47710451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185494926 | chr14:47710486-47710487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532604573 | chr14:47710497-47710498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552275851 | chr14:47710522-47710523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549281654 | chr14:47710527-47710528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569063445 | chr14:47710536-47710537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368646997 | chr14:47710554-47710555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548465883 | chr14:47710559-47710560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112709506 | chr14:47710590-47710591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534540509 | chr14:47710613-47710614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568463014 | chr14:47710622-47710623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574763801 | chr14:47710625-47710626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs17652736 | chr14:47710638-47710639 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs531816956 | chr14:47710639-47710640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs187960369 | chr14:47710649-47710650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs191319224 | chr14:47710658-47710659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs183824368 | chr14:47710666-47710667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575467778 | chr14:47710690-47710691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188441360 | chr14:47710716-47710717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368866301 | chr14:47710721-47710722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs368819408 | chr14:47710732-47710733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561162663 | chr14:47710800-47710801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574704596 | chr14:47710838-47710839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540173522 | chr14:47710853-47710854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556294158 | chr14:47710869-47710870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs200599614 | chr14:47710892-47710893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532663837 | chr14:47710906-47710907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372699551 | chr14:47710909-47710910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139540131 | chr14:47710988-47710989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs377493328 | chr14:47711054-47711055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181264845 | chr14:47711059-47711060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545852875 | chr14:47711103-47711104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184986831 | chr14:47711114-47711115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs17652760 | chr14:47711141-47711142 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs546730676 | chr14:47711173-47711174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548405196 | chr14:47711177-47711178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539587945 | chr14:47711183-47711184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76406902 | chr14:47711201-47711202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189915119 | chr14:47711257-47711258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547793220 | chr14:47711260-47711261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs566414365 | chr14:47711318-47711319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 21785460 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21858162 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Schizophrenia | 20967226 | CNVD |
Gastric cancer | 18160780 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:47710200-47710600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr14:47710200-47710600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr14:47710200-47710600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr14:47710200-47710600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr14:47710600-47713600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |